Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Methylprednisolone acetate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methylprednisolone acetate 40mg/1ml inj vials
1001022K0AAAAAA
|
Methylprednisolone acetate | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 13,902 |
|
Methylprednisolone 40mg / Lidocaine 10mg/1ml (1%) inj vials
1001022K0AAAGAG
|
Methylprednisolone acetate | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 8,730 |
|
Methylprednisolone 80mg / Lidocaine 20mg/2ml (1%) inj vials
1001022K0AAAFAF
|
Methylprednisolone acetate | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 5,162 |
|
Methylprednisolone acetate 80mg/2ml inj vials
1001022K0AAABAB
|
Methylprednisolone acetate | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 2,976 |
|
Methylprednisolone acetate 120mg/3ml inj vials
1001022K0AAAEAE
|
Methylprednisolone acetate | Methylprednisolone acetate | Musculoskeletal and Joint Diseases | 527 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.